Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

No Distinction Between House Mark and Trademark: Bombay HC Grants Relief to Sun Pharma, Bars ABSUN

Sun Pharma gets exclusive worldwide rights to commercialize Philogen anti-cancer immunotherapy Fibromun

Written By Ruchika Sharma1 Oct 2024 2:17 PM IST

Mumbai: Sun Pharmaceutical Industries Limited and Philogen S.p.A have announced that they have entered into a global licensing agreement for...

Biocon Biologics Secures BB+ Rating Upgrade from S&P on Improved Financial Metrics

Biocon gets 4 USFDA observations for Bengaluru facility

Written By Ruchika Sharma30 Sept 2024 6:45 PM IST

Bangalore: Biocon has announced that the U.S Food and Drug Administration (US FDA) has concluded a surveillance inspection with four...

Aurobindo Arm CuraTeQ Partners STADA Arzneimittel AG to Commercialise Biosimilars in Europe

Aurobindo Pharma arm Telangana facility gets 10 USFDA observations

Written By Ruchika Sharma30 Sept 2024 5:01 PM IST

Telangana: Aurobindo Pharma has announced that the United States Food and Drug Administration (US FDA) has issued ten observations at the closure...

USFDA Closes Inspection at Zydus Ankleshwar Unit-2 With Three Observations

USFDA issues EIR for Piramal Pharma Ahmedabad facility

Written By Ruchika Sharma30 Sept 2024 12:11 PM IST

Mumbai: Piramal Pharma has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (US FDA) for its...

Zydus Lifesciences gets USFDA nod for prostate cancer drug Enzalutamide

Written By Ruchika Sharma30 Sept 2024 11:15 AM IST

Ahmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) to manufacture...

CDSCO Panel Clears Bristol Myers Yervoy for Two New Cancer Indications

USFDA approves Bristol Myers Squibb Cobenfy for Schizophrenia treatment in adults

Written By Ruchika Sharma29 Sept 2024 10:00 AM IST

Princeton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has approved COBENFY (xanomeline and trospium...

Lupin rolls out constipation drug Prucalopride in US after USFDA nod

Upcoming 50 pharma manufacturing plants under PLI scheme to be completed in 2 years: Centre

Written By Ruchika Sharma28 Sept 2024 4:52 PM IST

New Delhi: The Centre has informed that the 50 upcoming pharmaceutical manufacturing plants under the production-linked incentive (PLI) scheme...

Alembic Secures USFDA Approval for Gilenya Generic

Alembic Pharma receives USFDA EIR for Oral solid formulation facility (F-1) at Panelav

Written By Ruchika Sharma28 Sept 2024 4:37 PM IST

Vadodara: Alembic Pharma has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (US FDA) for the...

Language Row Costs Pharmacist: Action Ordered for Giving Wrong Medicine, Refusing Bengali

Drugs in CDSCO samples Counterfeit, not ours, say leading pharma companies

Written By Ruchika Sharma28 Sept 2024 3:33 PM IST

New Delhi: After a series of media articles announcing the results of the Monthly CDSCO drug alert report and pointing how major pharma samples...

USFDA issues three observations each on API, Finished Product side of Lupin Pithampur facility

Written By Ruchika Sharma28 Sept 2024 12:15 PM IST

Mumbai: Lupin has announced that the United States Food and Drug Administration (USFDA) has issued three observations each on the API and...

Shilpa Biologicals, Stein Cares Ink Exclusive Biosimilar Licensing Pact for Latin America

Lupin arm ink pact with Celnova for distribution of Orphan Drug NaMuscla in Argentina, Colombia

Written By Ruchika Sharma28 Sept 2024 11:10 AM IST

Mumbai: Global pharma major, Lupin Limited has announced that its subsidiary Lupin Atlantis Holdings SA has entered into a distribution agreement...

After 40 Years, USFDA Approves Vanda Pharmas Motion Sickness Drug Nereus

Alembic Pharma receives USFDA approval for schizophrenia drug Paliperidone Extended Release

Written By Ruchika Sharma27 Sept 2024 4:40 PM IST

Mumbai: Alembic Pharmaceuticals Limited today announced that it has received final approval from the US Food & Drug Administration (USFDA)...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok